Immune‐Tolerant Hepatitis B: Maybe a Misnomer but Still Hard to Treat
Paul Martin – 9 April 2019
A Tale of Two Complications of Obesity: NASH and Hepatocellular Carcinoma
Renumathy Dhanasekaran, Dean W. Felsher – 8 April 2019
Letter to the Editor: Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis
Yu‐Jen Chen, Chia‐Fen Tsai, Yen‐Po Wang, Ching‐Liang Lu – 8 April 2019
Reply
Mayank Sharma, Siddharth Singh, Douglas A. Simonetto – 8 April 2019
Reply
Xin Chen, Satdarshan P. Monga, Diego F. Calvisi – 8 April 2019
Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol‐Inducible Cytochrome P450‐2E1–Mediated Oxidative and Nitrative Stress
Young‐Eun Cho, Do‐Kyun Kim, Wonhyo Seo, Bin Gao, Seong‐Ho Yoo, Byoung‐Joon Song – 8 April 2019 – Fructose intake is known to induce obesity, insulin resistance, metabolic syndrome, and nonalcoholic fatty liver disease (NAFLD). We aimed to evaluate the effects of fructose drinking on gut leakiness, endotoxemia, and NAFLD and study the underlying mechanisms in rats, mice, and T84 colon cells.
Letter to the Editor: Comment on Qiao et al.
Helene Gilgenkrantz, Christine Perret – 8 April 2019
Letter to the Editor: Proton Pump Inhibitors in Cirrhosis: A Marker of Morbid Conditions or a Cause of Mortality?
Andrew M. Moon, Paul H. Hayashi, A. Sidney Barritt – 5 April 2019
Reply
Raj Vuppalanchi, Naga Chalasani – 5 April 2019
Evaluation of a Multifaceted Intervention to Reduce Health Disparities in Hepatitis C Screening: A Pre‐Post Analysis
Mamta K. Jain, Nicole E. Rich, Chul Ahn, Barbara J. Turner, Joanne M. Sanders, Brian Adamson, Lisa Quirk, Patrice Perryman, Noel O. Santini, Amit G. Singal – 4 April 2019 – Hepatitis C virus (HCV) testing in persons born from 1945 to 1965 has had limited adoption despite guidelines, particularly among racial/ethnic minorities and socioeconomically disadvantaged patients, who have a higher prevalence of disease burden. We examined the effectiveness of a multifaceted intervention to improve HCV screening in a large safety‐net health system.